Anti‑hypertensive effect of crocin and hesperidin combination in high‑fat diet treated rats

Hashemzaei,Mahmoud; Rezaee,Ramin; Nabatzehi,Mojtaba; Tsarouhas,Konstantinos; Nikolouzakis,Taxiarchis Konstantinos; Lazopoulos,George; Spandidos,Demetrios A.; Tsatsakis,Aristidis; Shahraki,Jafar

doi:10.3892/etm.2020.8650

Anti‑hypertensive effect of crocin and hesperidin combination in high‑fat diet treated rats

Authors:
- Mahmoud Hashemzaei
- Ramin Rezaee
- Mojtaba Nabatzehi
- Konstantinos Tsarouhas
- Taxiarchis Konstantinos Nikolouzakis
- George Lazopoulos
- Demetrios A. Spandidos
- Aristidis Tsatsakis
- Jafar Shahraki
View Affiliations

Affiliations: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zabol University of Medical Sciences, 9861615881 Zabol, Iran, Clinical Research Unit, Faculty of Medicine, Mashhad University of Medical Sciences, 9177948564 Mashhad, Iran, Department of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece, Center of Toxicology Science and Research, Medical School, University of Crete, 71003 Heraklion, Greece, Department of Cardiothoracic Surgery, University General Hospital of Heraklion, Medical School, University of Crete, 71003 Heraklion, Greece, Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece
Published online on: April 8, 2020 https://doi.org/10.3892/etm.2020.8650
Pages: 3840-3844
Copyright: © Hashemzaei et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cardiovascular diseases are the leading cause of death worldwide. Hypertension is the most important cause of such conditions. The use of medicinal herbs is of particular importance due to their lower cost and side effects. The aim of the present study was to compare the effect of hesperidin (HES) and crocin (CRO) alone and in combination, on blood pressure in a rat model of high‑fat diet (HFD)‑induced hypertension, using invasive carotid artery measurements. Animals were randomly assigned to the following groups: control group (received standard chow diet), HFD control group (received HFD containing 32% kcal of fat and 0.1% cholesterol), and three groups of HFD‑treated animals that were treated with a single dose of CRO (20 mg/kg), HES (20 mg/kg), or CRO + HES (20 + 20 mg/kg). Except for the control group, rats received HFD for 7 weeks. On day 50, CRO, HES and normal saline were administered intraperitoneally and carotid arteries of the rats were cannulated. Three hours after the carotid artery cannulation, mean arterial blood pressure (MAP), systolic and diastolic blood pressure (SBP and DBP), and heart rate (HR) were measured using an intra‑arterial catheter with the use of a Power Lab system. Data was analyzed using SPSS software. Rats that received HFD for 49 days presented a significant increase in SBP, HR and MAP compared to the control group (P<0.001). Whereas, HFD‑treated rats of the CRO + HES group showed lower levels of SBP, HR and MAP; however, DBP remained unaffected. HES administration in HFD treated rats resulted in a significant decrease in SBP compared to the HFD control group with no significant differences in MAP. The hypotensive effects of the simultaneous administration of CRO and HES in HFD‑hypertensive rats suggest the need for further study of these two natural products as a potential preventive measure against hypertension development, especially in patients with high normal blood pressure.

View Figures

View References

1	Hashemzaei M, Abdollahzadeh M, Iranshahi M, Golmakani E, Rezaee R and Tabrizian K: Effects of luteolin and luteolin-morphine co-administration on acute and chronic pain and sciatic nerve ligated-induced neuropathy in mice. J Complement Integr Med. 14(20160066)2017.PubMed/NCBI View Article : Google Scholar
2	Hashemzaei M, Imen Shahidi M, Moallem SA, Abnous K, Ghorbani M and Mohamadpour AH: Modulation of JAK2, STAT3 and Akt1 proteins by granulocyte colony stimulating factor following carbon monoxide poisoning in male rat. Drug Chem Toxicol. 39:375–379. 2016.PubMed/NCBI View Article : Google Scholar
3	Hashemzaei M, Karami SP, Delaramifar A, Sheidary A, Tabrizian K, Rezaee R, Shahsavand S, Arsene AL, Tsatsakis AM and Taghdisi SM: Anticancer effects of co-administration of daunorubicin and resveratrol in MOLT-4, U266 B1 and Raji cell lines. Farmacia. 64:36–42. 2016.
4	Tabeshpour J, Hashemzaei M and Sahebkar A: The regulatory role of curcumin on platelet functions. J Cell Biochem. 119:8713–8722. 2018.PubMed/NCBI View Article : Google Scholar
5	Tabrizian K, Yaghoobi NS, Iranshahi M, Shahraki J, Rezaee R and Hashemzaei M: Auraptene consolidates memory, reverses scopolamine-disrupted memory in passive avoidance task, and ameliorates retention deficits in mice. Iran J Basic Med Sci. 18:1014–1019. 2015.PubMed/NCBI
6	Buijsse B, Weikert C, Drogan D, Bergmann M and Boeing H: Chocolate consumption in relation to blood pressure and risk of cardiovascular disease in German adults. Eur Heart J. 31:1616–1623. 2010.PubMed/NCBI View Article : Google Scholar
7	Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB and De Gaetano G: Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation. 105:2836–2844. 2002.PubMed/NCBI View Article : Google Scholar
8	Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA and Jacobs DR Jr: Flavonoid intake and cardiovascular disease mortality: A prospective study in postmenopausal women. Am J Clin Nutr. 85:895–909. 2007.PubMed/NCBI View Article : Google Scholar
9	Peters U, Poole C and Arab L: Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol. 154:495–503. 2001.PubMed/NCBI View Article : Google Scholar
10	Auclair S, Milenkovic D, Besson C, Chauvet S, Gueux E, Morand C, Mazur A and Scalbert A: Catechin reduces atherosclerotic lesion development in apo E-deficient mice: A transcriptomic study. Atherosclerosis. 204:e21–e27. 2009.PubMed/NCBI View Article : Google Scholar
11	Norata GD, Marchesi P, Passamonti S, Pirillo A, Violi F and Catapano AL: Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. Atherosclerosis. 191:265–271. 2007.PubMed/NCBI View Article : Google Scholar
12	Rezaee R, Jamialahmadi K, Riahi Zanjani B, Mahmoudi M, Abnous K, Zamani Taghizadeh Rabe S, Tabasi N, Zali M, Rezaee M, Amin B, et al: Crocin effects on human myeloma cells regarding intracellular redox state, DNA fragmentation, and apoptosis or necrosis profile. Jundishapur J Nat Pharm Prod. 9(e20131)2014.PubMed/NCBI View Article : Google Scholar
13	Rezaee R, Mahmoudi M, Abnous K, Zamani Taghizadeh Rabe S, Tabasi N, Hashemzaei M and Karimi G: Cytotoxic effects of crocin on MOLT-4 human leukemia cells. J Complement Integr Med. 10:105–112. 2013.PubMed/NCBI View Article : Google Scholar
14	Yaribeygi H, Mohammadi MT, Rezaee R and Sahebkar A: Crocin improves renal function by declining Nox-4, IL-18, and p53 expression levels in an experimental model of diabetic nephropathy. J Cell Biochem. 119:6080–6093. 2018.PubMed/NCBI View Article : Google Scholar
15	Lee IA, Lee JH, Baek NI and Kim DH: Antihyperlipidemic effect of crocin isolated from the fructus of Gardenia jasminoides and its metabolite Crocetin. Biol Pharm Bull. 28:2106–2110. 2005.PubMed/NCBI View Article : Google Scholar
16	Mashmoul M, Azlan A, Mohtarrudin N, Nisak B, Yusof M and Khaza’ai H: Saffron extract and crocin reduced biomarkers associated with obesity in rats fed a high-fat diet. Mal J Nutr. 23:117–127. 2017.
17	Anaeigoudari A, Faramarzi A, Abbasnezhad A and Shafei M: Effect of intrapertonal injection of crocin on cardiovascular parameters in Angiotensin II-induced hypertensive rats. Horizon Med Sci. 24:309–315. 2018.
18	Imenshahidi M, Razavi BM, Faal A, Gholampoor A, Mousavi SM and Hosseinzadeh H: Effects of chronic crocin treatment on desoxycorticosterone acetate (doca)-salt hypertensive rats. Iran J Basic Med Sci. 17:9–13. 2014.PubMed/NCBI
19	Imenshahidi M, Hosseinzadeh H and Javadpour Y: Hypotensive effect of aqueous saffron extract (Crocus sativus L.) and its constituents, safranal and crocin, in normotensive and hypertensive rats. Phytother Res. 24:990–994. 2010.PubMed/NCBI View Article : Google Scholar
20	He SY, Qian ZY and Tang FT: Effect of crocin on intracellular calcium concentration in cultured bovine aortic smooth muscle cells. Yao Xue Xue Bao. 39:778–781. 2004.(In Chinese):PubMed/NCBI
21	Williams BA, Liu C, Deyoung L, Brock GB and Sims SM: Regulation of intracellular Ca²⁺ release in corpus cavernosum smooth muscle: Synergism between nitric oxide and cGMP. Am J Physiol Cell Physiol. 288:C650–C658. 2005.PubMed/NCBI View Article : Google Scholar
22	Iranshahi M, Rezaee R, Parhiz H, Roohbakhsh A and Soltani F: Protective effects of flavonoids against microbes and toxins: The cases of hesperidin and hesperetin. Life Sci. 137:125–132. 2015.PubMed/NCBI View Article : Google Scholar
23	Parhiz H, Roohbakhsh A, Soltani F, Rezaee R and Iranshahi M: Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: An updated review of their molecular mechanisms and experimental models. Phytother Res. 29:323–331. 2015.PubMed/NCBI View Article : Google Scholar
24	Rezaee R, Sheidary A, Jangjoo S, Ekhtiary S, Bagheri S, Kohkan Z, Dadres M, Oana Docea A, Tsarouhas K, Sarigiannis DA, et al: Cardioprotective effects of hesperidin on carbon monoxide poisoned in rats. Drug Chem Toxicol: Aug 14, 2019 (Epub ahead of print).
25	Roohbakhsh A, Parhiz H, Soltani F, Rezaee R and Iranshahi M: Neuropharmacological properties and pharmacokinetics of the citrus flavonoids hesperidin and hesperetin - a mini-review. Life Sci. 113:1–6. 2014.PubMed/NCBI View Article : Google Scholar
26	Roohbakhsh A, Parhiz H, Soltani F, Rezaee R and Iranshahi M: Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases. Life Sci. 124:64–74. 2015.PubMed/NCBI View Article : Google Scholar
27	Haidari F, Heybar H, Jalali MT, Ahmadi Engali K, Helli B and Shirbeigi E: Hesperidin supplementation modulates inflammatory responses following myocardial infarction. J Am Coll Nutr. 34:205–211. 2015.PubMed/NCBI View Article : Google Scholar
28	Homayouni F, Haidari F, Hedayati M, Zakerkish M and Ahmadi K: Blood pressure lowering and anti-inflammatory effects of hesperidin in type 2 diabetes; a randomized double-blind controlled clinical trial. Phytother Res. 32:1073–1079. 2018.PubMed/NCBI View Article : Google Scholar
29	Morand C, Dubray C, Milenkovic D, Lioger D, Martin JF, Scalbert A and Mazur A: Hesperidin contributes to the vascular protective effects of orange juice: A randomized crossover study in healthy volunteers. Am J Clin Nutr. 93:73–80. 2011.PubMed/NCBI View Article : Google Scholar
30	Demonty I, Lin Y, Zebregs YE, Vermeer MA, van der Knaap HC, Jäkel M and Trautwein EA: The citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and women. J Nutr. 140:1615–1620. 2010.PubMed/NCBI View Article : Google Scholar
31	Rizza S, Muniyappa R, Iantorno M, Kim JA, Chen H, Pullikotil P, Senese N, Tesauro M, Lauro D, Cardillo C, et al: Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. J Clin Endocrinol Metab. 96:E782–E792. 2011.PubMed/NCBI View Article : Google Scholar
32	Ohtsuki K, Abe A, Mitsuzuwi H, Kondo M, Uemura K, Iwasaki Y and Kondo Y: Effects of long-term administration of hesperidin and glucosyl hesperidin to spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo). 48:420–422. 2002.PubMed/NCBI View Article : Google Scholar
33	Yamamoto M, Suzuki A and Hase T: Short-term effects of glucosyl hesperidin and hesperetin on blood pressure and vascular endothelial function in spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo). 54:95–98. 2008.PubMed/NCBI View Article : Google Scholar
34	Asgharpour A, Cazanave SC, Pacana T, Seneshaw M, Vincent R, Banini BA, Kumar DP, Daita K, Min H-K, Mirshahi F, et al: A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer. J Hepatol. 65:579–588. 2016.PubMed/NCBI View Article : Google Scholar
35	Lin HT, Shiou YL, Jhuang WJ and Lee HC: Simultaneous electrocardiography recording and invasive blood pressure measurement in rats. J Vis Exp. 143(e59115)2019.PubMed/NCBI View Article : Google Scholar
36	Parasuraman S and Raveendran R: Measurement of invasive blood pressure in rats. J Pharmacol Pharmacother. 3:172–177. 2012.PubMed/NCBI View Article : Google Scholar
37	Dobrian AD, Davies MJ, Prewitt RL and Lauterio TJ: Development of hypertension in a rat model of diet-induced obesity. Hypertension. 35:1009–1015. 2000.PubMed/NCBI View Article : Google Scholar
38	Ikemura M, Sasaki Y, Giddings JC and Yamamoto J: Preventive effects of hesperidin, glucosyl hesperidin and naringin on hypertension and cerebral thrombosis in stroke-prone spontaneously hypertensive rats. Phytother Res. 26:1272–1277. 2012.PubMed/NCBI View Article : Google Scholar
39	Wunpathe C, Potue P, Maneesai P, Bunbupha S, Prachaney P, Kukongviriyapan U, Kukongviriyapan V and Pakdeechote P: Hesperidin suppresses renin-angiotensin system mediated NOX2 over-expression and sympathoexcitation in 2K-1C hypertensive rats. Am J Chin Med. 46:751–767. 2018.PubMed/NCBI View Article : Google Scholar
40	Shafei MN, Faramarzi A, Khajavi Rad A and Anaeigoudari A: Crocin prevents acute angiotensin II-induced hypertension in anesthetized rats. Avicenna J Phytomed. 7:345–352. 2017.PubMed/NCBI
41	Imenshahidi M, Razavi BM, Faal A, Gholampoor A, Mousavi SM and Hosseinzadeh H: The effect of chronic administration of saffron (Crocus sativus) Stigma aqueous extract on systolic blood pressure in rats. Jundishapur J Nat Pharm Prod. 8:175–179. 2013.PubMed/NCBI View Article : Google Scholar
42	Llorens S, Mancini A, Serrano-Díaz J, D'Alessandro AM, Nava E, Alonso GL and Carmona M: Effects of crocetin esters and crocetin from Crocus sativus L. on aortic contractility in rat genetic hypertension. Molecules. 20:17570–17584. 2015.PubMed/NCBI View Article : Google Scholar
43	Mancini A, Serrano-Díaz J, Nava E, D'Alessandro AM, Alonso GL, Carmona M and Llorens S: Crocetin, a carotenoid derived from saffron (Crocus sativus L.), improves acetylcholine-induced vascular relaxation in hypertension. J Vasc Res. 51:393–404. 2014.PubMed/NCBI View Article : Google Scholar